Filter
2411
Filtered Results: 2411
Text search:
drug
regulation
Featured
Recommendations
187
New Publications
664
Language
Document type
No document type
1413
Studies & Reports
409
Guidelines
309
Manuals
120
Strategic & Response Plan
89
Fact sheets
23
Training Material
21
Situation Updates
14
Infographics
5
Brochures
4
Resource Platforms
4
Countries / Regions
India
107
Kenya
87
Global
80
Western and Central Europe
65
Nigeria
57
Uganda
54
South Africa
53
Ethiopia
53
Liberia
43
Sierra Leone
42
Tanzania
42
Ghana
41
Africa
40
Bangladesh
40
Latin America and the Carribbean
39
Nepal
38
Zambia
37
Malawi
33
Eastern Europe
30
Ukraine
28
Myanmar / Burma
28
Philippines
25
Rwanda
24
Namibia
24
Indonesia
24
South–East Asia Region
23
Zimbabwe
19
Asia
18
Lesotho
17
Cambodia
16
Russia
16
Syria
15
Botswana
15
Eswatini/ Swaziland
14
Congo, Democratic Republic of
11
Senegal
10
Pakistan
10
Mozambique
9
Venezuela
9
Thailand
8
Middle East and North Africa
8
Brazil
8
Georgia
8
Cameroon
7
Albania
7
USA
7
Haiti
7
Germany
7
Eastern Europe and Central Asia
7
Vietnam
7
Colombia
6
Burkina Faso
6
West and Central Africa
6
China
5
Laos
5
Western Pacific Region
5
East and Southern Africa
5
Sudan
5
Iraq
5
Tajikistan
4
El Salvador
4
Chile
4
Peru
4
Guinea
4
Argentina
4
Lebanon
4
Moldova
4
South Sudan
4
North Macedonia
3
Mexico
3
Turkey
3
Benin
3
Kyrgyzstan
3
Afghanistan
3
Jordan
3
Paraguay
3
Bolivia
3
Sri Lanka
3
Libya
3
Bhutan
3
Kazakhstan
2
Iran
2
Fiji
2
Uzbekistan
2
Morocco
2
Hungary
2
Portugal
2
Spain
2
Papua New Guinea
2
Yemen
2
Poland
2
Honduras
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Singapore
1
Estonia
1
Mongolia
1
Qatar
1
Italy
1
Lithuania
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Belarus
1
Southern Africa
1
Nicaragua
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Angola
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
962
Clinical Guidelines
163
Public Health
139
Women & Child Health
74
Key Resources
56
Pharmacy & Technologies
46
Capacity Building
22
Toolboxes
Mental Health
245
HIV
224
AMR
197
TB
159
Pharmacy
121
COVID-19
117
Rapid Response
59
NCDs
53
Planetary Health
52
Caregiver
51
NTDs
38
Ebola
35
Global Health Education
32
Refugee
30
Conflict
30
Disability
23
Health Financing Toolbox
16
Specific Hazards
14
Polio
11
Zika
8
Natural Hazards
7
Social Ethics
7
Cholera
5
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Le NCPI a été rempli au cours du 1er trimestre 2014 par une équipe technique de 17 personnes responsabilisées en sous-groupes pour les parties A, B et UA. Les réponses aux différentes questions se sont référées à celles de NCPI de 2012 pour permettre une meilleure logique. La responsabilit...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
The present National action plan on antimicrobial resistance (AMR) with component of antimicrobial consumption (AMC) covering both human and agriculture sectors was developed based on the World Health Organization's (WHO) Global plan on AMR dated 2015. With the purpose to develop this plan, in May 2...
The National Department of Health and Department of Agriculture, Forestry and Fisheries have collectively engaged to determine the key interventions that will form the basis for this strategy taking into account the recommendations from the WHO and OIE.
The development and implementation of a Natio...
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions aimed at reducing the main modifiable risk behaviours f...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ...
Fetal alcohol spectrum disorders (FASD) represent a range of physical, mental, and behavioral disabilities caused by alcohol use during pregnancy, or prenatal alcohol exposure (PAE). FASDs are considered to be one of the leading preventable causes of developmental disability. Despite its high preval...
Objectifs 2020 : des avancées disparates. Le rapport de l’ONUSIDA sur l’épidémie mondiale de sida fait état d’un échec accentué par la COVID-19. Depuis 2015, 3,5 millions d’infections au VIH et 820 000 morts supplémentaires liés au sida sont imputables à des objectifs non atteints. ...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Letter of the holy father
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
Practical considerations
It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and used together. The countries in South-East Asia and the Pacific regions would like to adapt the guidance...
India is experiencing rapid demographic and epidemiological transitions with NCDs causing significant disability, morbidity and mortality both in urban and rural populations and across all socioeconomic strata. According to the ICMR State Level Disease Burden Initiative, in 2016, NCDs accounted to a...
